DUSA – News and Analysis – DUSA Pharmaceuticals, Inc #jobs #in #pharmaceutical #industry

Posted On Dec 8 2017 by

#dusa pharma # DUSA is a vertically integrated dermatology company that is developing and marketing Levulan PDT and other products for common skin conditions. We operate in two segments, Photodynamic Therapy, or PDT, Drug and Device Products and Non-Photodynamic Therapy, or Non-PDT, Drug Products. Our Levulan® Kerastick® and BLU-U® products comprise our PDT segment, while Nicomide®, ClindaReach® and the other products acquired in the acquisition of Sirius comprise our Non-PDT segment. Our currently marketed products include among others Levulan® Kerastick® 20% Topical Solution with photodynamic therapy, the BLU-U® brand light source, and certain products acquired in the March 10, 2006 …


Pharmaceutical News, Industry Analysis, Market Research Reports – Pharmaceutical Business Review #pharma #consulting

Posted On Dec 7 2017 by

#pharmaceutical business # Pharmaceutical Business Review FDA approves Amgen’s BLINCYTO for pediatric acute lymphoblastic leukemia The US Food and Drug Administration (FDA) has approved Amgen’s supplemental Biologics License Application (sBLA) for BLINCYTO (blinatumomab) to include new data supporting the treatment of pediatric patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Regulatory Affairs News Biogen’s Alzheimer’s drug gets FDA fast-track status By PBR Staff Writer The US Food and Drug Administration (FDA) has granted fast track designation to Biogen’s investigational Alzheimer’s disease (AD) treatment aducanumab. Production Manufacturing Process Production News Singapore sees first case of …


GMP Pharmaceutical Analysis Laboratories #evaluate #pharma

Posted On Dec 3 2017 by

#gmp pharma # The Shale Oil and Gas Revolution has changed the energy world. Intertek has kept pace by providing crucial and timely exploration, production, quality, quantity inventory, compliance, certification, training, inspection and logistics support and expertise to an industry in radical transition. Demand for non-destructive testing (NDT) has grown and Intertek is meeting the growing market for these services. We are living a connected life, and Intertek works to ensure and optimize those connections via its testing services for the Internet of Things. The world has rules, and Intertek’s constant and continuing work in regulatory compliance brings you the …


Market Research Reports and Industry Analysis from JSB Market Research #epic #pharma

Posted On Dec 2 2017 by

#market research reports # Market Research Reports and Industry Analysis JSB Market Research Pvt.Ltd was formed in 2013 and the portal www.jsbmarketresearch.com for quality primary market research reports was launched to dedicatedly provide quick search service to global clients with no restriction to any industry verticals. We favour timeliness of deliverables as one of the prime points of business in today’s competitive market research arena. For us, the process adds value to our core business. But, as a competing firm with, JSB Market Research Pvt.Ltd is equally aligned to providing quality reports to clients. Accelerating business prospects with our market …


Indian Biotechnology Industry Analysis #government #pricing #pharma

Posted On Nov 27 2017 by

#biotechnology industry # Indian Biotechnology Industry Analysis Robust growth in Biotech industry Maintaining the momentum of the previous years, the Indian biotech industry grew 16.28 per cent in FY14; the total industry size was US$ 5 billion at the end of the financial year and it reached US$ 7 billion in FY15. Fast-paced growth is likely to continue; the industry is expected to increase in size to USD11.6 billion by 2017, driven by a range of factors such as growing demand, intensive R D activities and strong government initiatives Bio-pharma accounts for majority market share The bio-pharmaceutical segment accounted for …


GMP Pharmaceutical Analysis Laboratories #pharma #industry #trends

Posted On Nov 26 2017 by

#gmp pharma # The Shale Oil and Gas Revolution has changed the energy world. Intertek has kept pace by providing crucial and timely exploration, production, quality, quantity inventory, compliance, certification, training, inspection and logistics support and expertise to an industry in radical transition. Demand for non-destructive testing (NDT) has grown and Intertek is meeting the growing market for these services. We are living a connected life, and Intertek works to ensure and optimize those connections via its testing services for the Internet of Things. The world has rules, and Intertek’s constant and continuing work in regulatory compliance brings you the …


Market Research Reports, Forecasts and Industry Analysis from BCC Research #astellas #pharma

Posted On Nov 25 2017 by

#market research reports # Market Research Collections from BCC Research This BCC Research report deals exclusively with wireless technologies employed in the personal area network (PAN) and local area network (LAN) topologies. It forecasts the market size of wireless sensors from 2015 to 2021. This BCC Research report analyzes and measures the market for conventional conductive polymer composites, which incorporate conductive fillers in an insulative resin to achieve a measure of conductivity. Includes forecasts through 2021. This BCC Research report provides a comprehensive analysis of the pharmacy automation market’s current operations and equipment, current trends and detailed patent analysis. Structure …


Equity: Global Pharmaceuticals ETF: Holdings, Quote, Analysis, Ratings #pharma #advertising #agency

Posted On Nov 23 2017 by

#pharma etf # Equity: Global Pharmaceuticals ETF.com Insight Of the two choices for global pharmaceutical ETFs, neither provides a broad, neutral take on the segment. Both products take big leaps from the market portfolio in their selection and Both products take big leaps from the market portfolio weighting procedures that make them tilted takes on the global market.PPH is a descendent of the now-defunct HOLDRS ETFs, some of the earliest and simplest exchange- traded products. The current iteration of the fund is a traditional 1940 Act ETF, meaning unlike the old HOLDRS, it can reinvest dividends. The underlying index, however, …


Pharmaceutical News, Industry Analysis, Market Research Reports – Pharmaceutical Business Review #pharmaceutical #manufacturing #companies

Posted On Nov 21 2017 by

#pharmaceutical business # Pharmaceutical Business Review FDA approves Amgen’s BLINCYTO for pediatric acute lymphoblastic leukemia The US Food and Drug Administration (FDA) has approved Amgen’s supplemental Biologics License Application (sBLA) for BLINCYTO (blinatumomab) to include new data supporting the treatment of pediatric patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Regulatory Affairs News Biogen’s Alzheimer’s drug gets FDA fast-track status By PBR Staff Writer The US Food and Drug Administration (FDA) has granted fast track designation to Biogen’s investigational Alzheimer’s disease (AD) treatment aducanumab. Production Manufacturing Process Production News Singapore sees first case of …


Pharmaceutical Industry Analysis: Market Research, Survey, Growth & Reports #pharmaceutical #company #jobs

Posted On Nov 17 2017 by

#pharmaceutical industry analysis # Pharmaceutical Industry Analysis: Market Research, Survey, Growth & Reports Indian Pharma Sector India is among the top six global pharmaceutical producers in the world. Indian vaccines are exported to 150 countries. India produces 40-70 per cent of the WHO demand for DPT & BCG and 90 per cent of measles vaccine. Approximately 70 per cent of the patients in developing countries receive Indian medicines through NGOs like The Clinton Foundation, Bill & Melinda Gates Foundation, Doctors Without Borders, the UNCTAD etc. Presently there are 10,500 manufacturing units and over 3,000 pharma companies in India, growing at …